select by year: all years - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 1997

select by group: all groups - Sattler - Tetko - Niessing - Reif - Hagn - Zeidler - Popowicz - Alderson

Kazokaitė J, Niemans R, Dudutienė V, Becker HM, Leitāns J, Zubrienė A, Baranauskienė L, Gondi G, Zeidler R, Matulienė J, Tārs K, Yaromina A, Lambin P, Dubois LJ, Matulis D (2018)
Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells.
Oncotarget, Issue 42, Vol. 9, 26800-26816
DOI: 10.18632/oncotarget.25508, PubMed: 29928486

von Neubeck B, Gondi G, Riganti C, Pan C, Parra Damas A, Scherb H, Ertürk A, Zeidler R (2018)
An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo.
International journal of cancer, Issue 8, Vol. 143, 2065-2075
DOI: 10.1002/ijc.31607, PubMed: 29786141

Fiedler L, Kellner M, Oos R, Böning G, Ziegler S, Bartenstein P, Zeidler R, Gildehaus FJ, Lindner S (2018)
Fully Automated Production and Characterization of 64 Cu and Proof-of-Principle Small-Animal PET Imaging Using 64 Cu-Labelled CA XII Targeting 6A10 Fab.
ChemMedChem, Issue 12, Vol. 13, 1230-1237
DOI: 10.1002/cmdc.201800130, PubMed: 29667369

Gärtner K, Battke C, Dünzkofer J, Hüls C, von Neubeck B, Kellner MK, Fiestas E, Fackler S, Lang S, Zeidler R (2018)
Tumor-derived extracellular vesicles activate primary monocytes.
Cancer medicine, Issue 5, Vol. 7, 2013-2020
DOI: 10.1002/cam4.1465, PubMed: 29601673